Omnitarg pertuzumab: Phase III start
DNA said it plans to start a Phase III trial of Omnitarg pertuzumab plus Herceptin trastuzumab and
Gathering data...
DNA said it plans to start a Phase III trial of Omnitarg pertuzumab plus Herceptin trastuzumab and